CLINUVEL has upgraded its U.S. listing to the Nasdaq exchange under the ticker CUVL to enhance liquidity and visibility. Meanwhile, Rockwell Medical announced it has regained compliance with Nasdaq's minimum bid price requirements. Additionally, Scancell Holdings agreed to an all-share merger with Neuphoria Therapeutics to secure its own Nasdaq listing.
